Company Presentation • 01 Nov 2024 04:30
Company Presentation • 24 Oct 2024 20:30
Company Presentation • 07 Aug 2024 04:30
Company Presentation • 06 Jun 2024 20:30
Company Presentation • 08 May 2024 04:30
ENTITY
Halozyme Therapeutics (HALO US)
Halozyme Therapeutics (HALO US)
12
Analysis
Health Care • United States
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
more
x